Related Experiment Video
Updated: May 4, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
[Corrigendum] Temozolomide-induced modification of the CXC chemokine network in experimental gliomas
Céline Bruyère1, Tatjana Mijatovic, Caroline Lonez
1Département de BioAnalyse et de Toxicologie Pharmaceutique, Laboratoire de Toxicologie, Faculté de Pharmacie, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Abstract:
After the publication of the article, the authors noted an error. The changes are as follows: In the initial and published version of Fig. 5, the data relied on triplicates in both the control (SCR) and treated (siCXCL2)conditions. In fact, the experiments were carried out in tetraplicates. However, the cells in one of the control (SCR) replicates died for unknown reasons. Thus, the data are here presented as the means ± SEM calculated from triplicates in the SCR control condition and from tetraplicates in the siCXCL2 condition. Therefore, shown below is the corrected version of Fig. 5.

